🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jean‐Pierre Llanos

Amgen (United States)

ORCID: 0000-0002-7785-6881

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Clinical response and on-treatment clinical remission with tezepelumab in a broad population of patients with severe, uncontrolled asthma: results over 2 years from the NAVIGATOR and DESTINATION studies”.

Clinical response and on-treatment clinical remission with tezepelumab in a broad population of patients with severe, uncontrolled asthma: results over 2 years from the NAVIGATOR and DESTINATION studies

European Respiratory Journal(2024)10.1183/13993003.00316-2024

N/A

1.4DataRank · unranked

43 citations

Guy Brusselle, J. Christian Virchow, Arnaud Bourdin, Κonstantinos Κostikas, Jean‐Pierre Llanos +10 more

Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study

Advances in Therapy(2024)10.1007/s12325-024-02889-8

N/A

0.713DataRank · unranked

22 citations

Wendy C. Moore, Monica Kraft, Guy Brusselle, Mario Castro, Geoffrey Chupp +8 more

Biologic therapy in rare eosinophil-associated disorders: remaining questions and translational research opportunities

Journal of Leukocyte Biology(2024)10.1093/jleuko/qiae051

N/A

0DataRank · unranked

5 citations

Florence Roufosse, Fei Li Kuang, Steven J. Ackerman, Praveen Akuthota, Bruce S. Bochner +68 more